Bioequivalence Study of Pantoprazole Sodium-HPBCD and Conventional Pantoprazole Sodium Enteric-Coated Tablet Formulations

Table 2

The mean and 90% confidence intervals (CI) of pharmacokinetic parameters of the test product (Tripepsa) compared to the reference product (Pantocid).

Pharmacokinetic parameter	Mean ratio (%)	90% CI (%)	Bioequivalence limit (%)
Ratio of 𝐶max	108.68	100.21–117.86	80–125
Ratio of AUC0-∞	90.21	83.69–97.24	80–125
Ratio of AUC0−𝑡	96.78	89.56–104.58	70–143